Has Megan Gosse received payments from drug or device companies?

Yes. Drug and device makers reported $3,361 in general payments to Megan Gosse across 216 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Megan Gosse did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Megan Gosse come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Megan Gosse

Psychiatric/Mental Health · Iowa City, IANPI 1467976779

Payments from drug & device makers

$3,361in general payments, 2019–2025

Across 216 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$642
AbbVie$456
Supernus Pharmaceuticals, Inc.$401
Otsuka America Pharmaceutical, Inc.$397
Takeda Pharmaceuticals U.S.A., Inc.$187
Neurocrine Biosciences, Inc.$182
plus $1K from 18 others

What the payments were for

Food & beverage$3,361100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	67	$642
AbbVie	40	$456
Supernus Pharmaceuticals, Inc.	10	$401
Otsuka America Pharmaceutical, Inc.	18	$397
Takeda Pharmaceuticals U.S.A., Inc.	11	$187
Neurocrine Biosciences, Inc.	11	$182
Alkermes, Inc.	8	$153
Corium, LLC	5	$119
Vanda Pharmaceuticals Inc.	5	$116
Axsome Therapeutics, Inc.	6	$96
Bausch Health US, LLC	5	$89
Ironshore Pharmaceuticals Inc.	4	$80
Lundbeck LLC	4	$63
Adlon Therapeutics L.p.	3	$53
Teva Pharmaceuticals USA, Inc.	3	$53
Collegium Pharmaceutical, Inc.	2	$42
Almatica Pharma LLC	3	$40
Harmony Biosciences LLC	2	$40
Jazz Pharmaceuticals Inc.	2	$36
Idorsia Pharmaceuticals US Inc	2	$29
Neuronetics, Inc.	1	$28
Sunovion Pharmaceuticals Inc.	2	$23
Johnson & Johnson	1	$18
E.r. Squibb & Sons, L.L.C.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

QELBREE$198

How this compares

$3,361 in reported general payments places this provider in the 80th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluoxetine Hcl	13	$287
Clonazepam	21	$190

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Iowa City

Ann GlickIowa City$6K
Tarrah HollidayAtlantic$421K
Kelsie SwisherParkersburg$235K
Jennifer BradleyCedar Rapids$66K
Kama AusbornWaterloo$64K
Quentin ChambersDes Moines$40K
Tenaea JeppesonFort Dodge$38K
Jennifer WittmanCoralville$25K
Amy MorinCedar Rapids$24K
Jenna BerendzenCedar Falls$22K

See the full list for Iowa →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →